Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

Macroprolactinoma in a young man presenting with erectile dysfunction

  • Song, Seung-Hun (Department of Urology, Fertility Center of CHA Gangnam Medical Center, CHA University College of Medicine) ;
  • Lee, Jinil (Department of Andrology Laboratory, Fertility Center of CHA Gangnam Medical Center, CHA University College of Medicine) ;
  • Kim, Dong Suk (Department of Urology, Fertility Center of CHA Gangnam Medical Center, CHA University College of Medicine)
  • Received : 2019.06.17
  • Accepted : 2019.08.09
  • Published : 2019.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Hyperprolactinemia due to a pituitary adenoma is a rare cause of erectile dysfunction (ED). The prevalence of clinically apparent prolactinomas is reported to be from 6-10 to 50 per 100,000. A few reports have been published of prolactinoma presenting with ED. Here, we report a rare case of a young man who presented with ED as a chief complaint and who was diagnosed with a huge prolactinoma, and we discuss a related fertility issue.

Keywords

References

  1. Majumdar A, Mangal NS. Hyperprolactinemia. J Hum Reprod Sci 2013;6:168-75. https://doi.org/10.4103/0974-1208.121400
  2. Zeitlin SI, Rajfer J. Hyperprolactinemia and erectile dysfunction. Rev Urol 2000;2:39-42.
  3. Buchfelder M, Schlaffer S. Imaging of pituitary pathology. Handb Clin Neurol 2014;124:151-66. https://doi.org/10.1016/B978-0-444-59602-4.00011-3
  4. Gillam MP, Molitch ME, Lombardi G, Colao A. Advances in the treatment of prolactinomas. Endocr Rev 2006;27:485-534. https://doi.org/10.1210/er.2005-9998
  5. Barker FG 2nd, Klibanski A, Swearingen B. Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 2003;88:4709-19. https://doi.org/10.1210/jc.2003-030461
  6. Buvat J. Hyperprolactinemia and sexual function in men: a short review. Int J Impot Res 2003;15:373-7. https://doi.org/10.1038/sj.ijir.3901043
  7. Masud S, Mehboob F, Bappi MU. Severe hyperprolactinaemia directly depresses the gonadal activity causing infertility. Esculapio J Services Inst Med Sci 2007;2:25-7.
  8. Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA 2017;317:516-24. https://doi.org/10.1001/jama.2016.19699
  9. De Rosa M, Colao A, Di Sarno A, Ferone D, Landi ML, Zarrilli S, et al. Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine. Eur J Endocrinol 1998;138:286-93. https://doi.org/10.1530/eje.0.1380286
  10. Colao A, Vitale G, Cappabianca P, Briganti F, Ciccarelli A, De Rosa M, et al. Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Metab 2004;89:1704-11. https://doi.org/10.1210/jc.2003-030979
  11. Klibanski A. Clinical practice: prolactinomas. N Engl J Med 2010;362:1219-26. https://doi.org/10.1056/NEJMcp0912025
  12. Hout WM, Arafah BM, Salazar R, Selman W. Evaluation of the hypothalamic-pituitary-adrenal axis immediately after pituitary adenomectomy: is perioperative steroid therapy necessary? J Clin Endocrinol Metab 1988;66:1208-12. https://doi.org/10.1210/jcem-66-6-1208
  13. Paluzzi A, Fernandez-Miranda JC, Tonya Stefko S, Challinor S, Snyderman CH, Gardner PA. Endoscopic endonasal approach for pituitary adenomas: a series of 555 patients. Pituitary 2014;17:307-19. https://doi.org/10.1007/s11102-013-0502-4